Is your medical device biochemical reagents and formulation services partner prepared to weather supply chain challenges?

Supply chain security and transparency a key parts of the risk mitigation strategy of companies manufacturing medical devices. Prior to the COVID-19 crisis, complex global supply chains carefully balanced capacity with demand while cost-cutting initiatives pushed toward lower-cost raw material providers located in different geographies. COVID-19-driven regional manufacturing shutdowns, surge demands, and logistics disruptions have placed significant pressure on manufacturing supply chains, resulting in raw material shortages and delays.